Clinical trial
Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic…
NCT00185510 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00185510 |
|---|---|
| Title | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis |
| Official title | Double-Blind, Placebo Controlled, Randomized, Multicenter, Parallel-Group Study to Compare the Efficacy and Safety of Advantan Cream Twice Weekly With Advabase Cream During a Maintenance Phase of 16 Weeks After Successful Treatment of Atopic Dermatitis With Advantan Cream |
| Lead sponsor | LEO Pharma, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dermatitis, Atopic |
| Intervention type | Drug |
| Interventions | Methylprednisolone Aceponate (Advantan, BAY86-4862), Placebo |
| Enrollment | 250 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 9, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: